CCG
Cypress Capital Group’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479K | Buy |
+1,182
| New | +$479K | 0.06% | 154 |
|
|
2023
Q4 | – | Sell |
-724
| Closed | -$366K | – | 302 |
|
|
2023
Q3 | $366K | Sell |
724
-143
| -16% | -$72.4K | 0.05% | 238 |
|
|
2023
Q2 | $452K | Buy |
867
+347
| +67% | +$181K | 0.07% | 226 |
|
|
2023
Q1 | $300K | Buy |
520
+105
| +25% | +$60.5K | 0.05% | 248 |
|
|
2022
Q4 | $229K | Buy |
+415
| New | +$229K | 0.03% | 275 |
|
|
2022
Q2 | – | Sell |
-691
| Closed | -$408K | – | 305 |
|
|
2022
Q1 | $408K | Buy |
691
+315
| +84% | +$186K | 0.05% | 233 |
|
|
2021
Q4 | $251K | Sell |
376
-142
| -27% | -$94.8K | 0.03% | 280 |
|
|
2021
Q3 | $296K | Buy |
518
+52
| +11% | +$29.7K | 0.04% | 243 |
|
|
2021
Q2 | $235K | Sell |
466
-213
| -31% | -$107K | 0.03% | 256 |
|
|
2021
Q1 | $310K | Sell |
679
-110
| -14% | -$50.2K | 0.04% | 235 |
|
|
2020
Q4 | $368K | Buy |
789
+227
| +40% | +$106K | 0.06% | 224 |
|
|
2020
Q3 | $248K | Buy |
+562
| New | +$248K | 0.04% | 229 |
|
|
2020
Q1 | – | Sell |
-620
| Closed | -$201K | – | 239 |
|
|
2019
Q4 | $201K | Buy |
+620
| New | +$201K | 0.04% | 236 |
|
|
2019
Q3 | – | Sell |
-926
| Closed | -$272K | – | 250 |
|
|
2019
Q2 | $272K | Buy |
926
+96
| +12% | +$28.2K | 0.05% | 206 |
|
|
2019
Q1 | $227K | Buy |
+830
| New | +$227K | 0.05% | 225 |
|